Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

High-risk group of upper and middle mediastinal lymph node metastasis in patients with esophagogastric junction carcinoma.

Yura M, Takeuchi H, Fukuda K, Nakamura R, Suda K, Wada N, Kawakubo H, Kitagawa Y.

Ann Gastroenterol Surg. 2018 Oct 13;2(6):419-427. doi: 10.1002/ags3.12215. eCollection 2018 Nov.

2.

Rehmannia glutinosa polysaccharide functions as a mucosal adjuvant to induce dendritic cell activation in mediastinal lymph node.

Kwak M, Yu K, Lee PC, Jin JO.

Int J Biol Macromol. 2018 Dec;120(Pt B):1618-1623. doi: 10.1016/j.ijbiomac.2018.09.187. Epub 2018 Sep 30.

PMID:
30282011
3.

Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.

Katsura M, Shoji F, Okamoto T, Shimamatsu S, Hirai F, Toyokawa G, Morodomi Y, Tagawa T, Oda Y, Maehara Y.

Cancer Sci. 2018 Jan;109(1):154-165. doi: 10.1111/cas.13422. Epub 2017 Nov 9.

4.

Conventional Transbronchial Needle Aspiration: The Original Guard Who Still Has a Role in Mediastinal Lymph Node Sampling.

Mehta RM, Singla A, Balaji AL, Krishnamurthy S, Bhat RS, Lokanath C.

J Bronchology Interv Pulmonol. 2017 Oct;24(4):290-295. doi: 10.1097/LBR.0000000000000410.

PMID:
28957889
5.

Discrimination of Malignant versus Benign Mediastinal Lymph Nodes Using Diffusion MRI with an IVIM Model.

Qi LP, Yan WP, Chen KN, Zhong Z, Li XT, Cai K, Sun YS, Zhou XJ.

Eur Radiol. 2018 Mar;28(3):1301-1309. doi: 10.1007/s00330-017-5049-8. Epub 2017 Sep 19.

PMID:
28929210
6.

Impact of EBUS-TBNA on PET-CT Imaging of Mediastinal Nodes.

Sivapalan P, Naur TMH, Colella S, Richter Larsen K, Konge L, Frost Clementsen P.

J Bronchology Interv Pulmonol. 2017 Jul;24(3):188-192. doi: 10.1097/LBR.0000000000000373.

PMID:
28696964
7.

Increase of Frequency and Modulation of Phenotype of Regulatory T Cells by Atorvastatin Is Associated with Decreased Lung Inflammatory Cell Infiltration in a Murine Model of Acute Allergic Asthma.

Blanquiceth Y, Rodríguez-Perea AL, Tabares Guevara JH, Correa LA, Sánchez MD, Ramírez-Pineda JR, Velilla PA.

Front Immunol. 2016 Dec 21;7:620. doi: 10.3389/fimmu.2016.00620. eCollection 2016.

8.

Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes.

Wang HH, Zaorsky NG, Meng MB, Zeng XL, Deng L, Song YC, Zhuang HQ, Li FT, Zhao LJ, Yuan ZY, Wang P, Hao XS.

Oncotarget. 2016 Apr 5;7(14):18135-45. doi: 10.18632/oncotarget.7636.

9.

Low-dose benzo[a]pyrene aggravates allergic airway inflammation in mice.

Yanagisawa R, Koike E, Win-Shwe TT, Ichinose T, Takano H.

J Appl Toxicol. 2016 Nov;36(11):1496-504. doi: 10.1002/jat.3308. Epub 2016 Feb 25.

PMID:
26918773
10.

Lymph node evaluation in totally thoracoscopic lobectomy with two-port for clinical early-stage nonsmall-cell lung cancer: Single-center experience of 1086 cases.

Yang R, Jiao W, Zhao Y, Qiu T, Wang Y, Luo Y.

Indian J Cancer. 2015 Dec;52 Suppl 2:e134-9. doi: 10.4103/0019-509X.172511.

11.

Candidates for Intensive Local Treatment in cIIIA-N2 Non-Small Cell Lung Cancer: Deciphering the Heterogeneity.

Horinouchi H, Goto Y, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Sumi M, Tamura T, Ohe Y.

Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):155-162. doi: 10.1016/j.ijrobp.2015.09.026. Epub 2015 Sep 26.

12.

Interleukin-21-Producing CD4(+) T Cells Promote Type 2 Immunity to House Dust Mites.

Coquet JM, Schuijs MJ, Smyth MJ, Deswarte K, Beyaert R, Braun H, Boon L, Karlsson Hedestam GB, Nutt SL, Hammad H, Lambrecht BN.

Immunity. 2015 Aug 18;43(2):318-30. doi: 10.1016/j.immuni.2015.07.015.

13.

Electromagnetic navigation-guided TBNA vs conventional TBNA in the diagnosis of mediastinal lymphadenopathy.

Diken ÖE, Karnak D, Çiledağ A, Ceyhan K, Atasoy Ç, Akyar S, Kayacan O.

Clin Respir J. 2015 Apr;9(2):214-20. doi: 10.1111/crj.12126. Epub 2014 Mar 20.

PMID:
25849298
14.

Basophil-associated OX40 ligand participates in the initiation of Th2 responses during airway inflammation.

Di C, Lin X, Zhang Y, Zhong W, Yuan Y, Zhou T, Liu J, Xia Z.

J Biol Chem. 2015 May 15;290(20):12523-36. doi: 10.1074/jbc.M115.642637. Epub 2015 Apr 3.

15.

[Analyses of risk factors for postoperative recurrence after curative resection of stage III A-N2 non-small cell lung cancer].

Qiang G, Guo Y, Xiao F, Yu Q, Liang C, Song Z, Tian Y, Shi B, Liu D.

Zhonghua Yi Xue Za Zhi. 2014 Nov 11;94(41):3239-43. Chinese.

PMID:
25604225
16.

Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC).

Xu L, Tian J, Liu Y, Li C.

J Magn Reson Imaging. 2014 Jul;40(1):200-5. doi: 10.1002/jmri.24343. Epub 2013 Oct 29.

PMID:
24923480
17.

Clinical applications of SPECT/CT after first I-131 ablation in patients with differentiated thyroid cancer.

Jeong SY, Lee SW, Kim HW, Song BI, Ahn BC, Lee J.

Clin Endocrinol (Oxf). 2014 Sep;81(3):445-51. doi: 10.1111/cen.12460. Epub 2014 May 5.

PMID:
24716874
18.
19.

Mediastinal lymph-nodes metastasis beyond the lobe-specific: an independent risk factor toward worse prognoses.

Sun Y, Gao W, Zheng H, Jiang G, Chen C, Zhang L.

Ann Thorac Cardiovasc Surg. 2014;20(4):284-91. Epub 2013 Jun 18.

20.

Correlation between [¹⁸F]FDG PET/CT and volume perfusion CT in primary tumours and mediastinal lymph nodes of non-small-cell lung cancer.

Sauter AW, Spira D, Schulze M, Pfannenberg C, Hetzel J, Reimold M, Klotz E, Claussen CD, Horger MS.

Eur J Nucl Med Mol Imaging. 2013 May;40(5):677-84. doi: 10.1007/s00259-012-2318-2. Epub 2013 Jan 10.

PMID:
23306806

Supplemental Content

Loading ...
Support Center